Iridex (IRIX) Debt Ratio (2020 - 2021)

Name: Iridex (IRIX) Debt Ratio (2020 - 2021) | Business Quant
Creator: Business Quant

Iridex's quarterly Debt Ratio came in at 0.04 in Q2 2021, down 1.27% quarter-over-quarter from 0.04 in Q1 2021.

Iridex has reported Debt Ratio for 2 years, with the latest figure at 0.04 in Q2 2021.

For the quarter ending Q2 2021, Debt Ratio changed N/A year-over-year to 0.04; the trailing twelve-month figure through Apr 2021 stood at 0.04 (changed N/A YoY), and the FY2021 full-year result was 0.04, changed N/A from the prior year.
Debt Ratio for Q2 2021 stood at 0.04, down from 0.04 in the prior quarter.
The five-year high for Debt Ratio was 0.05 in Q3 2020, with the low at 0.04 in Q2 2021.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn	0.31
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn	0.32
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn	0.31
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn	0.25
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn	0.04
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	0.25
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn	0.27
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn	0.18
10	Iridex	18.87 Mn	14.27 Mn	4.74 Mn	-

Download Data 🔒